Medications FDA Approves Nucala (mepolizumab) as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)
Medications Analysis finds big drugmakers could lose $1 trillion in sales and still be most profitable industry
Medications Study reveals possible solution to elevated cancer risk from important anti-infection drug
Medications Antidepressants can lead to reductions in behavioral and neural responses to pain empathy
